Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) has earned a consensus recommendation of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among […]